- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Schizophrenia
- Meeting Date: March 2022
- Public Summary Document (PSD) March 2022 PBAC Meeting - (PDF 479KB)
- Public Summary Document (PSD) March 2022 PBAC Meeting - (Word 88KB)
Paliperidone – March 2022
Paliperidone: I.M. injection (modified release) 700 mg (as palmitate) in pre-filled syringe, I.M. injection (modified release) 1000 mg (as palmitate) in pre-filled syringe; Invega Hafyera®
Last updated
1 July 2022